878672-00-5 2-((5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid
BD435045878672-00-598%
¥197.0250mg
471-05-6 (2E,6E,10E)-2,6,9,9-Tetramethylcycloundeca-2,6,10-trienone
BD272624471-05-695%
¥3397.0100mg
1151516-14-1 Sodium 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate
BD3329541151516-14-198%
¥238.0250mg
1352792-74-5 2-((3-(4-Cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid
BD6301691352792-74-598+%
¥768.050mg
2268720-62-1 1-((5-Bromo-4-((4-bromonaphthalen-1-yl)methyl)-4H-1,2,4-triazol-3-yl)thio)-N-(pyridin-3-yl)methanesulfonamide
BD011397982268720-62-199+%
1638327-48-6 1-((6-Bromoquinolin-4-yl)thio)cyclobutane-1-carboxylic acid
BD012216161638327-48-698%
1198153-15-9 (3,5-Dibromo-4-hydroxyphenyl)(2,3-dihydro-4H-pyrido[4,3-b][1,4]oxazin-4-yl)methanone
BD012743521198153-15-998%
2803951-18-8 URAT1 inhibitor 2
BD015088082803951-18-898%
2760615-09-4 KPH2f
BD015026482760615-09-498%
2365178-28-3 Xininurad
BD015666682365178-28-398%
2013582-27-7 Puliginurad
BD015983322013582-27-798%
2700292-02-8 N-((4-Bromophenyl)sulfonyl)-2-((3-(4-cyclopropylnaphthalen-1-yl)-4-oxo-3,4-dihydrothieno[2,3-d]pyrimidin-2-yl)thio)acetamide
BD016995822700292-02-898%
2102670-94-8 URAT1 inhibitor 5
BD021710272102670-94-898%
1632005-33-4 URAT1 inhibitor 8
BD021676211632005-33-498%
1632002-28-8 URAT1 inhibitor 7
BD021828651632002-28-898%
2244807-49-4 URAT1 inhibitor 6
BD021911052244807-49-498%
2850331-30-3 URAT1 inhibitor 3
BD023353522850331-30-398%
2088176-96-7 Lingdolinurad
BD023046342088176-96-798%
1